Overview: Human Metapneumovirus PCR TestIntroduction: The Human Metapneumovirus PCR Test detects human metapneumovirus (hMPV) to diagnose respiratory infection, causing cough or fever. Following 2023 IDSA guidelines, it uses PCR for high specificity, supporting infectious disease screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in virology for patients with suspected respiratory viral infections.
Other Names: hMPV PCR Assay, Metapneumovirus Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: hMPV was identified in 2001. PCR-based testing improved in the 2010s, enhancing diagnostic precision for respiratory viruses.
Purpose: Detects hMPV to diagnose respiratory infection, guides antiviral or supportive therapy, and evaluates patients with cough or fever.
Test Parameters: 1. Human Metapneumovirus
Pretest Condition: No fasting required. Collect swab, BAL, or sputum at any time. Report symptoms like cough, fever, or respiratory distress.
Specimen: 1-2 swabs (sterile swab/transport medium), 5-10 mL bronchoalveolar lavage (sterile container), or 5-10 mL sputum (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document cough, fever, respiratory distress, or immunocompromised status. Include current medications, especially antivirals or steroids.
Consent: Written consent required, detailing the tests purpose, infection implications, and potential need for antiviral or supportive therapy.
Procedural Considerations: Uses PCR to detect hMPV RNA. Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for respiratory infection diagnosis.
Factors Affecting Result Accuracy: Improper sample collection or contamination can affect results. Low viral load may reduce sensitivity.
Clinical Significance: Positive hMPV confirms respiratory infection, guiding supportive or antiviral therapy. Negative results may require testing for other respiratory viruses.
Specialist Consultation: Consult an infectious disease specialist or pulmonologist for result interpretation and treatment planning.
Additional Supporting Tests: Influenza PCR, RSV PCR, or chest imaging to assess respiratory infections.
Test Limitations: Limited to hMPV; other respiratory viruses may cause similar symptoms. Clinical correlation is needed.
References: IDSA Respiratory Virus Guidelines, 2023; Journal of Infectious Diseases, Williams JV, 2022.
